首页> 外文期刊>Cell death & disease. >P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression
【24h】

P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression

机译:P53调控的长非编码RNA TUG1部分通过表观遗传调控HOXB7的表达影响人非小细胞肺癌的细胞增殖

获取原文
           

摘要

Recently, a novel class of transcripts, long non-coding RNAs (lncRNAs), is being identified at a rapid pace. These RNAs have critical roles in diverse biological processes, including tumorigenesis. Here we report that taurine-upregulated gene 1 ( TUG1 ), a 7.1-kb lncRNA, recruiting and binding to polycomb repressive complex 2 (PRC2), is generally downregulated in non-small cell lung carcinoma (NSCLC) tissues. In a cohort of 192 NSCLC patients, the lower expression of TUG1 was associated with a higher TNM stage and tumor size, as well as poorer overall survival ( P P in vitro and in vivo . Moreover, the lncRNA-mediated regulation of the expression of HOX genes in tumorigenesis and development has been recently receiving increased attention. Interestingly, inhibition of TUG1 could upregulate homeobox B7 (HOXB7) expression; ChIP assays demonstrated that the promoter of HOXB7 locus was bound by EZH2 (enhancer of zeste homolog 2), a key component of PRC2, and was H3K27 trimethylated. This TUG1-mediated growth regulation is in part due to specific modulation of HOXB7, thus participating in AKT and MAPK pathways. Together, these results suggest that p53-regulated TUG1 is a growth regulator, which acts in part through control of HOXB7. The p53/TUG1/PRC2/HOXB7 interaction might serve as targets for NSCLC diagnosis and therapy.
机译:最近,一种新型的转录本,即长非编码RNA(lncRNA)正在迅速被发现。这些RNA在包括肿瘤发生在内的多种生物学过程中都起着至关重要的作用。在这里我们报告牛磺酸上调基因1(TUG1),一个7.1-kb lncRNA,募集并结合到多梳抑制复合物2(PRC2),通常在非小细胞肺癌(NSCLC)组织中被下调。在192名NSCLC患者队列中,TUG1的较低表达与较高的TNM分期和肿瘤大小以及较差的总体存活率(体外和体内PP)有关。此外,lncRNA介导的HOX表达调节有趣的是,抑制TUG1可以上调同源盒B7(HOXB7)的表达; ChIP分析表明HOXB7基因座的启动子与EZH2(zeste同源物2的增强子)结合,引起了人们越来越多的关注。 TUG1介导的生长调节部分是由于HOXB7的特异调节,因此参与了AKT和MAPK途径,共同表明p53调节的TUG1是一种生长调节剂,其作用是p53 / TUG1 / PRC2 / HOXB7的相互作用可能是NSCLC诊断和治疗的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号